Center for Health Data Science & Analytics

101913

Citations

13

Faculty With Academic Appointments

234

Peer-reviewed Publications in 2024

About the Center

Services We Provide

The Center for Health Data Science & Analytics (HDSA) is a data service center comprised of data scientists, data analysts, and statisticians who work with clinicians and researchers to:


  • Explore,
  • Collate,
  • Harmonize, and
  • Analyze data from multiple sources and angles.

 

 

Job Opportunities


Research Data Scientist - Digital Health Institute
Research Data Scientist - Digital Health Institute

Services We Provide

  • Research data pipeline development and maintenance
  • Workflow optimization, innovative tracking, predictive and advanced analytics, outcomes measures, and cost reduction for quality improvement & population health management
  • Statistical and advanced modeling techniques to different types of data
  • Coordinate with clinicians and in supporting developing recommendations, grants, manuscripts and presentations for a variety of audiences and stakeholders
  • Clinical and lab experimental design and data analyses using a unique expertise in mathematics and statistics
  • Developing and applying machine learning and artificial intelligence applications to biomedical data
  • Statistical power and sample size determination, inferential hypothesis testing, linear and non-linear programming, algorithm development and numerical methods, computational intelligence, data mining, creating databases in REDCap
Our Leadership
Jones_512x768
Director
Stephen L. Jones, MD, MSHI
Occidental Petroleum Centennial Chair in Quality and Outcomes Research, Center for Health Data Science and Analytics
Associate Research Professor of Medical Informatics in Surgery, Academic Institute
Member, Research Institute, Academic Institute
Director, Center for Health Data Science and Analytics
Department of Surgery
J.C. Walter Jr. Transplant Center
Houston Methodist Hospital
Houston Methodist
Weill Cornell Medical College
Co-Director
Khurram Nasir, MD, MPH
William A. Zoghbi, MD Centennial Chair in Cardiovascular Health, DeBakey Heart & Vascular Center
Professor of Cardiology, Academic Institute
Jerold B. Katz Investigator, Academic Institute
Member, Research Institute, Academic Institute
Chief, Division of Cardiovascular Prevention and Wellness, Department of Cardiology
Co-director, Center for Health Data Science and Analytics
Houston Methodist Hospital
Houston Methodist
Weill Cornell Medical College
Research Administrator
Jennifer Taylor, MBA
Research News
doctor holding a tablet with a chest scan on it's screen
Personalized Treatment Strategies for Lung Cancer
Houston Methodist researchers identified a novel and innovative marker to guide Immune Checkpoint Inhibitor Therapy for Lung Cancer.
woman sitting on an examination table in a doctor's office
Trailblazing New Perspectives: Treating Gynecological Cancers
The goal of this new study was to evaluate the feasibility of a phase three, multi-center randomized clinical trial comparing the efficacy of minimally invasive surgery with that of the traditional open method approach (laparotomy) in treating epithelial ovarian cancer.
arm in blood pressure testing machine
Getting to the Heart of Hypertension Disparities
Researchers address social risk factors for high blood pressure through a national study.
Evolving Treatment Beyond Pharmaceuticals
First-of-its-Kind Study Explores Novel Prescription Digital Therapeutic
An Unusual Presentation of Glioblastoma
Andrew Lee, MD, Herb and Jean Lyman Centennial Chair in Ophthalmology, recently published one of the first-ever reported cases of progressive vision loss as the presenting manifestation of recurrent GBM with secondary LMS to the optic chiasm.
Engaging T cell Exhaustion for Solid Tumor Immunotherapies
Houston Methodist researchers investigated T cell exhaustion in murine models of prostate cancer and melanoma to explore possible advancements in immunotherapies for solid tumors.
Fighting a Deadly Duo
Investigating therapeutics to fight deadly TB/HIV coinfections.
Houston Methodist, Rice University launch groundbreaking Digital Health Institute
This initiative builds on ongoing collaborations between Houston Methodist and Rice University to transform the future of health care.
Stage I Nodal Marginal Zone Lymphoma Treatment Landscape
Houston Methodist researchers compared systemic therapy and radiation therapy in Stage I Nodal Marginal Zone Lymphoma Patients
2024 Digital Health Workshop Seed Fund Award Winners Announced
Houston Methodist researchers and their collaborators from Rice University have been awarded grants from the 2024 PATHS-UP Digital Health Workshop.
Pilot Study Offers Insight Into Alzheimer’s Research Participants Perceptions and Self-Efficacy
In a Houston Methodist study, Alzheimer’s disease research participants showed a high interest in genetic testing and provided valuable insights that can improve how test results are disclosed.
Breast Cancer Cells
Nanomedicine Makes Big Strides in the Fight Against Breast Cancer
Researchers deliver immunotherapy directly into triple-negative breast cancer tumors with nanofluidic implants, achieving tunable and sustained dosing of immunotherapeutics with high anti-tumor activity.
headshot of Constance Mobley smiling
Liver Failure Avengers Houston Methodist Researchers First in World
Under the leadership of Constance Mobley, MD, PhD, FACS, researchers have successfully performed a first-in-human miniature liver hepatocyte transplant to change a patient’s lymph nodes into ectopic miniature livers.
Predicting the Future of Cancer Treatment

Houston Methodist faculty developed a multiscale mechanistic model to further investigate the role of miR-155 in non-small cell lung cancer and predict clinical efficacy based on preclinical data.

Taking a Closer Look at West Nile Neuroimaging

A case report reviewing West Nile neuroinvasive disease imaging characteristics and the differential diagnosis of acute leukoencephalopathy highlights the usefulness of neuroimaging in WNND diagnosis in the absence of CSF markers.

Ending Organ Transplant Rejection

Studies at Houston Methodist suggest a novel strategy that may potentially eliminate or diminish transplant rejection, autoimmune diseases, and the need for immunosuppressive drugs

Location, Location, Location is Key to Pancreatic Cancer Prognosis

Molecular alterations found in pancreatic ductal adenocarcinoma samples may have potential therapeutic implications

Explore the following:

Donate to Houston Methodist

With your support, Houston Methodist provides exceptional research, education, and care that is truly leading medicine.

Donate Now